VIVXF News and Press, Avivagen From 03/18/21

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Corporation”),a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, ther...

Avivagen (VIVXF) announces that it will request approval from the TSX Venture Exchange for the extension of the expiration date of warrants exercisable to purchase 2.8M shares at $0.90/share, which were originally issued in 2016.The warrants currently have an expiration date of March 31, 2021...

Study to be published soon in leading peer-reviewed journal Poultry Science . Poultry Science is an internationally renowned journal, known as the authoritative source for a broad range of poultry information and high-caliber research. Avivagen Inc. (...

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that enhance feed intake and safely support immune f...

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that enhance feed intake and safely support immune function, thereby supporting general...

Mimi’s Rock Corp. (TSXV:MIMI) and Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), are pleased to announce the launch of Dr. Tobias Beta Blend available today through Amazon.com and DrTobias.com . An exclusive formula featuring a Beta-Carotene Nor...

Significant and ongoing order complements previous ten tonne order from established customer Industrias Melder Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, comp...

Avivagen, Inc. (VIVXF): FY Revenue of C$1.18M (+20.4% Y/Y)Press Release For further details see: Avivagen, Inc. reports FY results

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Company”) today reported its audited financial results for the fiscal year ended October 31, 2020. Unless otherwise noted, all figures are in Canadian currency. “By all measures, Avivagen ac...

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, the...